{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:13:24Z","timestamp":1791332004092,"version":"4.3.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hallucinations have been described in various clinical populations, but they are neither disorder nor disease specific. In schizophrenia patients, hallucinations are hallmark symptoms and auditory ones are described as the more frequent. In Parkinson\u2019s disease, the descriptions of hallucination modalities are sparse, but the hallucinations do tend to have less negative consequences. Our study aims to explore the phenomenology of hallucinations in both hallucinating schizophrenia patients and Parkinson\u2019s disease patients using the\n                    <jats:italic>Psycho-Sensory hAllucinations Scale<\/jats:italic>\n                    (PSAS). The main objective is to describe the phenomena of these clinical symptoms in those two specific populations. Each hallucinatory sensory modality significantly differed between Parkinson\u2019s disease and schizophrenia patients. Auditory, olfactory\/gustatory and c\u0153nesthetic hallucinations were more frequent in schizophrenia than visual hallucinations. The guardian angel item, usually not explored in schizophrenia, was described by 46% of these patients. The combination of auditory and visual hallucinations was the most frequent for both Parkinson\u2019s disease and schizophrenia. The repercussion index summing characteristics of each hallucination (frequency, duration, negative aspects, conviction, impact, control and sound intensity) was always higher for schizophrenia. A broader view including widespread characteristics and interdisciplinary works must be encouraged to better understand the complexity of the process involved in hallucinations.\n                  <\/jats:p>","DOI":"10.1038\/srep38152","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T05:34:51Z","timestamp":1480570491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Hallucinations in schizophrenia and Parkinson\u2019s disease: an analysis of sensory modalities involved and the repercussion on patients"],"prefix":"10.1038","volume":"6","author":[{"given":"P. M.","family":"Llorca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jardri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Chereau-Boudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Misdrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"F\u00e9nelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Tronche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Derost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Debilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Durif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"de Chazeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"BFsrep38152_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). (New School Library, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"577","key":"BFsrep38152_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1192\/bjp.123.6.621","volume":"123","author":"Gordon R. Lowe","year":"1973","unstructured":"Lowe, G. R. The phenomenology of hallucinations as an aid to differential diagnosis. Br J Psychiatry 123, 621\u2013633 (1973).","journal-title":"British Journal of Psychiatry"},{"key":"BFsrep38152_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000093922","volume":"39","author":"F Laroi","year":"2006","unstructured":"Laroi, F., Van der Linden, M., DeFruyt, F., van Os, J. & Aleman, A. Associations between delusion proneness and personality structure in non-clinical participants: comparison between young and elderly samples. Psychopathology 39, 218\u2013226, doi: 10.1159\/000093922 (2006).","journal-title":"Psychopathology"},{"key":"BFsrep38152_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/schbul\/sbs061","volume":"38","author":"F Laroi","year":"2012","unstructured":"Laroi, F. et al. The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions. Schizophr Bull 38, 724\u2013733, doi: 10.1093\/schbul\/sbs061 (2012).","journal-title":"Schizophr Bull"},{"key":"BFsrep38152_CR5","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1093\/schbul\/sbu036","volume":"40","author":"F Waters","year":"2014","unstructured":"Waters, F. et al. Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease. Schizophr Bull 40 Suppl 4, S233\u2013245, doi: 10.1093\/schbul\/sbu036 (2014).","journal-title":"Schizophr Bull"},{"key":"BFsrep38152_CR6","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.1093\/schbul\/sbu011","volume":"40","author":"JM Ford","year":"2014","unstructured":"Ford, J. M. et al. Studying hallucinations within the NIMH RDoC framework. Schizophr Bull 40 Suppl 4, S295\u2013304, doi: 10.1093\/schbul\/sbu011 (2014).","journal-title":"Schizophr Bull"},{"key":"BFsrep38152_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fnhum.2014.00180","volume":"8","author":"JC Badcock","year":"2014","unstructured":"Badcock, J. C. & Hugdahl, K. A synthesis of evidence on inhibitory control and auditory hallucinations based on the Research Domain Criteria (RDoC) framework. Front Hum Neurosci 8, 180, doi: 10.3389\/fnhum.2014.00180 (2014).","journal-title":"Front Hum Neurosci"},{"key":"BFsrep38152_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09638237.2011.562262","volume":"20","author":"V Beavan","year":"2011","unstructured":"Beavan, V., Read, J. & Cartwright, C. The prevalence of voice-hearers in the general population: a literature review. J Ment Health 20, 281\u2013292, doi: 10.3109\/09638237.2011.562262 (2011).","journal-title":"J Ment Health"},{"key":"BFsrep38152_CR9","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/mds.23835","volume":"26","author":"CG Goetz","year":"2011","unstructured":"Goetz, C. G., Stebbins, G. T. & Ouyang, B. Visual plus nonvisual hallucinations in Parkinson\u2019s disease: development and evolution over 10 years. Mov Disord 26, 2196\u20132200, doi: 10.1002\/mds.23835 (2011).","journal-title":"Mov Disord"},{"key":"BFsrep38152_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","volume":"289","author":"G Fenelon","year":"2010","unstructured":"Fenelon, G. & Alves, G. Epidemiology of psychosis in Parkinson\u2019s disease. J Neurol Sci 289, 12\u201317, doi: 10.1016\/j.jns.2009.08.014 (2010).","journal-title":"J Neurol Sci"},{"key":"BFsrep38152_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/jnnp.64.4.533","volume":"64","author":"R Inzelberg","year":"1998","unstructured":"Inzelberg, R., Kipervasser, S. & Korczyn, A. D. Auditory hallucinations in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 64, 533\u2013535 (1998).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFsrep38152_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/jnnp-2012\u2013302414","volume":"83","author":"S Bannier","year":"2012","unstructured":"Bannier, S. et al. Prevalence and phenomenology of olfactory hallucinations in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 83, 1019\u20131021, doi: 10.1136\/jnnp-2012\u2013302414 (2012).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFsrep38152_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","volume":"123","author":"G Fenelon","year":"2000","unstructured":"Fenelon, G., Mahieux, F., Huon, R. & Ziegler, M. Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors. Brain 123 (Pt 4), 733\u2013745 (2000).","journal-title":"Brain"},{"key":"BFsrep38152_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000314875","volume":"30","author":"H Katzen","year":"2010","unstructured":"Katzen, H. et al. Multi-modal hallucinations and cognitive function in Parkinson\u2019s disease. Dement Geriatr Cogn Disord 30, 51\u201356, doi: 10.1159\/000314875 (2010).","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BFsrep38152_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.schres.2014.11.010","volume":"161","author":"I de Chazeron","year":"2015","unstructured":"de Chazeron, I. et al. Validation of a Psycho-Sensory hAllucinations Scale (PSAS) in schizophrenia and Parkinson\u2019s disease. Schizophr Res 161, 269\u2013276, doi: 10.1016\/j.schres.2014.11.010 (2015).","journal-title":"Schizophr Res"},{"key":"BFsrep38152_CR16","doi-asserted-by":"crossref","unstructured":"Leucht, S. et al. Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method. Schizophr Bull, doi: 10.1093\/schbul\/sbu001 (2014).","DOI":"10.1093\/schbul\/sbu001"},{"key":"BFsrep38152_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinthera.2005.12.003","volume":"28","author":"S Thobois","year":"2006","unstructured":"Thobois, S. Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson\u2019s disease: a review of the literature. Clin Ther 28, 1\u201312 (2006).","journal-title":"Clin Ther"},{"key":"BFsrep38152_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13, 261\u2013276 (1987).","journal-title":"Schizophr Bull"},{"key":"BFsrep38152_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55, 181\u2013184 (1992).","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"BFsrep38152_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.1047","volume":"16","author":"Susanne Goldstein","year":"2001","unstructured":"The Unified Parkinson\u2019s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord18, 738\u2013750, doi: 10.1002\/mds.10473 (2003).","journal-title":"Movement Disorders"},{"key":"BFsrep38152_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2307\/2311865","volume":"70","author":"DW Henderson","year":"1963","unstructured":"Henderson, D. W. Venn diagrams for more than four classes. American Mathematical Monthly 70, 424\u2013426 (1963).","journal-title":"American Mathematical Monthly"},{"key":"BFsrep38152_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1176\/appi.ajp.157.2.172","volume":"157","author":"R Howard","year":"2000","unstructured":"Howard, R., Rabins, P. V., Seeman, M. V. & Jeste, D. V. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry 157, 172\u2013178, doi: 10.1176\/appi.ajp.157.2.172 (2000).","journal-title":"The International Late-Onset Schizophrenia Group. Am J Psychiatry"},{"key":"BFsrep38152_CR23","doi-asserted-by":"crossref","unstructured":"Aleman, A. & Laroi, F. Hallucinations: The Science of Idiosyncratic Perception. (American Psychological Association, 2008).","DOI":"10.1037\/11751-000"},{"key":"BFsrep38152_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1755\u20135949.2011.00247.x","volume":"18","author":"L Burghaus","year":"2012","unstructured":"Burghaus, L., Eggers, C., Timmermann, L., Fink, G. R. & Diederich, N. J. Hallucinations in neurodegenerative diseases. CNS Neurosci Ther 18, 149\u2013159, doi: 10.1111\/j.1755\u20135949.2011.00247.x (2012).","journal-title":"CNS Neurosci Ther"},{"key":"BFsrep38152_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0924-9338(03)00028-2","volume":"19","author":"F Laroi","year":"2004","unstructured":"Laroi, F., Marczewski, P. & Van der Linden, M. Further evidence of the multi-dimensionality of hallucinatory predisposition: factor structure of a modified version of the Launay-Slade Hallucinations Scale in a normal sample. Eur Psychiatry 19, 15\u201320, doi: 10.1016\/s0924-9338(03)00028-2 (2004).","journal-title":"Eur Psychiatry"},{"key":"BFsrep38152_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s2215-0366(15)00006-1","volume":"2","author":"A Woods","year":"2015","unstructured":"Woods, A., Jones, N., Alderson-Day, B., Callard, F. & Fernyhough, C. Experiences of hearing voices: analysis of a novel phenomenological survey. Lancet Psychiatry 2, 323\u2013331, doi: 10.1016\/s2215-0366(15)00006-1 (2015).","journal-title":"Lancet Psychiatry"},{"key":"BFsrep38152_CR27","first-page":"231","volume":"38","author":"MG Harish","year":"1996","unstructured":"Harish, M. G., Suresh, K. P., Rajan, I., Reddy, Y. C. & Khanna, S. Phenomenological study of late-onset schizophrenia. Indian J Psychiatry 38, 231\u2013235 (1996).","journal-title":"Indian J Psychiatry"},{"key":"BFsrep38152_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.parkreldis.2014.06.006","volume":"20","author":"K Zhu","year":"2014","unstructured":"Zhu, K., van Hilten, J. J. & Marinus, J. Predictors of dementia in Parkinson\u2019s disease; findings from a 5-year prospective study using the SCOPA-COG. Parkinsonism Relat Disord 20, 980\u2013985, doi: 10.1016\/j.parkreldis.2014.06.006 (2014).","journal-title":"Parkinsonism Relat Disord"},{"key":"BFsrep38152_CR29","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.wnl.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak, H., Rub, U., Jansen Steur, E. N., Del Tredici, K. & de Vos, R. A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64, 1404\u20131410, doi: 10.1212\/01.wnl.0000158422.41380.82 (2005).","journal-title":"Neurology"},{"key":"BFsrep38152_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0010-440X(84)90007-5","volume":"25","author":"K Koehler","year":"1984","unstructured":"Koehler, K. & Sauer, H. Jaspers\u2019 sense of presence in the light of Huber\u2019s basic symptoms and DSM-III. Compr Psychiatry 25, 183\u2013191 (1984).","journal-title":"Compr Psychiatry"},{"key":"BFsrep38152_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1136\/jnnp.2010.234799","volume":"82","author":"G Fenelon","year":"2011","unstructured":"Fenelon, G., Soulas, T., Cleret de Langavant, L., Trinkler, I. & Bachoud-Levi, A. C. Feeling of presence in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 82, 1219\u20131224, doi: 10.1136\/jnnp.2010.234799 (2011).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFsrep38152_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.psychres.2009.01.030","volume":"177","author":"P Rocca","year":"2010","unstructured":"Rocca, P., Castagna, F., Mongini, T., Montemagni, C. & Bogetto, F. Relative contributions of psychotic symptoms and insight to quality of life in stable schizophrenia. Psychiatry Res 177, 71\u201376, doi: 10.1016\/j.psychres.2009.01.030 (2010).","journal-title":"Psychiatry Res"},{"key":"BFsrep38152_CR33","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/schbul\/sbl071","volume":"33","author":"SM Eack","year":"2007","unstructured":"Eack, S. M. & Newhill, C. E. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 33, 1225\u20131237, doi: 10.1093\/schbul\/sbl071 (2007).","journal-title":"Schizophr Bull"},{"key":"BFsrep38152_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.0001-690X.2003.00237.x","volume":"109","author":"D Wiersma","year":"2004","unstructured":"Wiersma, D., Jenner, J. A., Nienhuis, F. J. & van de Willige, G. Hallucination focused integrative treatment improves quality of life in schizophrenia patients. Acta Psychiatr Scand 109, 194\u2013201 (2004).","journal-title":"Acta Psychiatr Scand"},{"key":"BFsrep38152_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.parkreldis.2004.12.005","volume":"11","author":"M Behari","year":"2005","unstructured":"Behari, M., Srivastava, A. K. & Pandey, R. M. Quality of life in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 11, 221\u2013226, doi: 10.1016\/j.parkreldis.2004.12.005 (2005).","journal-title":"Parkinsonism Relat Disord"},{"key":"BFsrep38152_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.parkreldis.2007.05.009","volume":"14","author":"A McKinlay","year":"2008","unstructured":"McKinlay, A. et al. A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson\u2019s disease patients without dementia. Parkinsonism Relat Disord 14, 37\u201342, doi: 10.1016\/j.parkreldis.2007.05.009 (2008).","journal-title":"Parkinsonism Relat Disord"},{"key":"BFsrep38152_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1017\/s0033291712002206","volume":"43","author":"VM Goghari","year":"2013","unstructured":"Goghari, V. M., Harrow, M., Grossman, L. S. & Rosen, C. A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders. Psychol Med 43, 1151\u20131160, doi: 10.1017\/s0033291712002206 (2013).","journal-title":"Psychol Med"},{"key":"BFsrep38152_CR38","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/brain\/awt257","volume":"136","author":"R Jardri","year":"2013","unstructured":"Jardri, R. & Deneve, S. Circular inferences in schizophrenia. Brain 136, 3227\u20133241, doi: 10.1093\/brain\/awt257 (2013).","journal-title":"Brain"},{"key":"BFsrep38152_CR39","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/cercor\/bhs082","volume":"23","author":"R Jardri","year":"2013","unstructured":"Jardri, R., Thomas, P., Delmaire, C., Delion, P. & Pins, D. The neurodynamic organization of modality-dependent hallucinations. Cereb Cortex 23, 1108\u20131117, doi: 10.1093\/cercor\/bhs082 (2013).","journal-title":"Cereb Cortex"},{"key":"BFsrep38152_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.schres.2009.12.028","volume":"117","author":"MJ Escarti","year":"2010","unstructured":"Escarti, M. J. et al. Increased amygdala and parahippocampal gyrus activation in schizophrenic patients with auditory hallucinations: an fMRI study using independent component analysis. Schizophr Res 117, 31\u201341, doi: 10.1016\/j.schres.2009.12.028 (2010).","journal-title":"Schizophr Res"},{"key":"BFsrep38152_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/schbul\/sbs156","volume":"40","author":"S McCarthy-Jones","year":"2014","unstructured":"McCarthy-Jones, S. et al. A new phenomenological survey of auditory hallucinations: evidence for subtypes and implications for theory and practice. Schizophr Bull 40, 231\u2013235, doi: 10.1093\/schbul\/sbs156 (2014).","journal-title":"Schizophr Bull"},{"key":"BFsrep38152_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.encep.2014.07.002","volume":"40","author":"A Gras","year":"2014","unstructured":"Gras, A., Amad, A., Thomas, P. & Jardri, R. [Hallucinations and borderline personality disorder: a review]. Encephale 40, 431\u2013438, doi: 10.1016\/j.encep.2014.07.002 (2014).","journal-title":"Encephale"},{"key":"BFsrep38152_CR43","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3389\/fpsyg.2015.01071","volume":"6","author":"S McCarthy-Jones","year":"2015","unstructured":"McCarthy-Jones, S. & Longden, E. Auditory verbal hallucinations in schizophrenia and post-traumatic stress disorder: common phenomenology, common cause, common interventions? Front Psychol 6, 1071, doi: 10.3389\/fpsyg.2015.01071 (2015).","journal-title":"Front Psychol"},{"key":"BFsrep38152_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427\u2013442 (1967).","journal-title":"Neurology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep38152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38152","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T20:35:23Z","timestamp":1672864523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep38152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep38152"],"URL":"https:\/\/doi.org\/10.1038\/srep38152","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]},"assertion":[{"value":"5 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author Llorca P.-M. reports grants from Lilly, personal fees from Janssen, nonfinancial support from Roche, and grants from Otsuka, all outside the submitted work. Author Renaud Jardri reports personal fees for lectures: Lundbeck, Astra-Zeneca, Janssen-Cilag, Otsuka pharmaceutical, Shire and GlaxoSmithKline, all outside of the submitted work Author Brousse G. reports personal fees from Lundbeck, Janssen-Cilag and Otsuka pharmaceutical, all outside of the submitted work. Author F\u00e9nelon G. reports personal fees from Lundbeck and Teva Pharma, all outside the submitted work. Author Schwan R. reports grants from Boucharad and personal fees from Lundbeck, Janssen-Cilag, Otsuka pharmaceutical and Reckitt-Bekinson, all outside of the submitted work. Author Durif F. reports grants from CHU Clermont Ferrand, during the conduct of the study; grants from Novartis SA, Lundbeck, and Merz; and personal fees from Novartis SA, Lundbeck, Allergan, Aguettant, Teva Pharma, and Servier, all outside the submitted work. All other authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38152"}}